These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7477739)

  • 21. New developments in the understanding of cerebral vasoregulation and vasospasm: the endothelin-nitric oxide network.
    Ehrenreich H; Schilling L
    Cleve Clin J Med; 1995; 62(2):105-16. PubMed ID: 7736628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
    Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W
    Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.
    Zhang Y; Belayev L; Zhao W; Irving EA; Busto R; Ginsberg MD
    Brain Res; 2005 May; 1045(1-2):150-6. PubMed ID: 15910773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelin in cerebral vasospasm. Clinical and experimental results.
    Zimmermann M
    J Neurosurg Sci; 1997 Jun; 41(2):139-51. PubMed ID: 9385564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased endothelin-1 in the rabbit model of middle cerebral artery occlusion.
    Bian LG; Zhang TX; Zhao WG; Shen JK; Yang GY
    Neurosci Lett; 1994 Jun; 174(1):47-50. PubMed ID: 7970153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin: an endothelium-derived vasoactive peptide and its possible role in the pathogenesis of cerebral vasospasm.
    Alafaci C; Salpietro FM; Iacopino DG; Edvinsson L; Tomasello F
    Ital J Neurol Sci; 1991 Jun; 12(3 Suppl 11):55-8. PubMed ID: 1757224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm.
    Cirak B; Kiymaz N; Ari HH; Ugras S
    Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm.
    Shigeno T; Clozel M; Sakai S; Saito A; Goto K
    Neurosurgery; 1995 Jul; 37(1):87-90; discussion 90-1. PubMed ID: 8587696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EndothelinA receptor antagonist BSF-208075 causes immune modulation and neuroprotection after stroke in gerbils.
    Hauck EF; Hoffmann JF; Heimann A; Kempski O
    Brain Res; 2007 Jul; 1157():138-45. PubMed ID: 17506996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic endothelin antagonism restores cerebrovascular function in diabetes.
    Dumont AS; Dumont RJ; McNeill JH; Kassell NF; Sutherland GR; Verma S
    Neurosurgery; 2003 Mar; 52(3):653-60; discussion 659-60. PubMed ID: 12590691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrovascular dysfunction is an attractive target for therapy in heat stroke.
    Chen SH; Niu KC; Lin MT
    Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):663-72. PubMed ID: 16895537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of endothelin receptor type A antagonism and nitric oxide synthase inhibition on cerebral blood flow in hypertensive rats.
    Granstam SO; Granstam E; Fellström B; Lind L
    Acta Physiol Scand; 1998 Oct; 164(2):213-8. PubMed ID: 9805108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs.
    Nirei H; Hamada K; Shoubo M; Sogabe K; Notsu Y; Ono T
    Life Sci; 1993; 52(23):1869-74. PubMed ID: 8318117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic implications of endothelin antagonists for cardiovascular diseases].
    Abassi Z; Ramadan R; Schwartz H; Hoffman A
    Harefuah; 2004 Jan; 143(1):47-53, 84. PubMed ID: 14748289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rat model of endothelin-3-induced middle cerebral artery occlusion with controlled reperfusion.
    Henshall DC; Butcher SP; Sharkey J
    Brain Res; 1999 Oct; 843(1-2):105-11. PubMed ID: 10528116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From bench-to-bedside in catastrophic cerebrovascular disease: development of drugs targeting the endothelin axis in subarachnoid hemorrhage-related vasospasm.
    Ardelt A
    Neurol Res; 2012 Mar; 34(2):195-210. PubMed ID: 22333896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelins and the role of endothelin antagonists in the management of posttraumatic vasospasm.
    Armstead WM
    Curr Pharm Des; 2004; 10(18):2185-92. PubMed ID: 15281894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelins-1/3 and endothelin-A/B receptors expressing glial cells with special reference to activated microglia in experimentally induced cerebral ischemia in the adult rats.
    Li JJ; Wu LH; Cao Q; Yuan Y; Yang L; Guo ZY; Kaur C; Sivakumar V; Ling EA; Wu CY
    Neuroscience; 2010 May; 167(3):665-77. PubMed ID: 20206236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.